Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Cynamon

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|July 25, 2003
Gatifloxacin and ethionamide as the foundation for therapy of tuberculosisMichael H Cynamon, Mary Sklaney
Drug Design and Discovery|November 24, 2004
In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosisMichael J Hearn, Michael H Cynamon
The Journal of Antimicrobial Chemotherapy|December 23, 2003
Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff baseMichael J Hearn, Michael H Cynamon
Frontiers in Microbiology|October 16, 2018
Therapy for <i>Mycobacterium kansasii</i> Infection: Beyond 2018Michelle S DeStefano, Carolyn M Shoen, Michael H Cynamon
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 4, 2004
The activity of grepafloxacin in two murine models of Mycobacterium avium infectionMichael H Cynamon, Mary Sklaney, Anthony E T Yeo
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosisEnrique J Alvirez-Freites, Janna L Carter, Michael H Cynamon
Journal of Bacteriology|May 6, 2003
Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Michael H Cynamon, et al.
Journal of Bacteriology|July 18, 2003
Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acidsVinod S Dubey, Tatiana D Sirakova, Michael H Cynamon, et al.
Expert Opinion on Investigational Drugs|January 31, 2003
Development potential of rifalazilDavid M Rothstein, Arthur D Hartman, Michael H Cynamon, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infectionMichael H Cynamon, Shannon A Elliott, Michelle S DeStefano, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 25, 2003
Gatifloxacin and ethionamide as the foundation for therapy of tuberculosisMichael H Cynamon, Mary Sklaney
Drug Design and Discovery|November 24, 2004
In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosisMichael J Hearn, Michael H Cynamon
The Journal of Antimicrobial Chemotherapy|December 23, 2003
Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff baseMichael J Hearn, Michael H Cynamon
Frontiers in Microbiology|October 16, 2018
Therapy for <i>Mycobacterium kansasii</i> Infection: Beyond 2018Michelle S DeStefano, Carolyn M Shoen, Michael H Cynamon
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 4, 2004
The activity of grepafloxacin in two murine models of Mycobacterium avium infectionMichael H Cynamon, Mary Sklaney, Anthony E T Yeo
Antimicrobial Agents and Chemotherapy|March 19, 2002
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosisEnrique J Alvirez-Freites, Janna L Carter, Michael H Cynamon
Journal of Bacteriology|May 6, 2003
Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Michael H Cynamon, et al.
Journal of Bacteriology|July 18, 2003
Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acidsVinod S Dubey, Tatiana D Sirakova, Michael H Cynamon, et al.
Expert Opinion on Investigational Drugs|January 31, 2003
Development potential of rifalazilDavid M Rothstein, Arthur D Hartman, Michael H Cynamon, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2003
Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infectionMichael H Cynamon, Shannon A Elliott, Michelle S DeStefano, et al.
Pageof 3